278 related articles for article (PubMed ID: 22281005)
1. TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors.
Kang BH
BMB Rep; 2012 Jan; 45(1):1-6. PubMed ID: 22281005
[TBL] [Abstract][Full Text] [Related]
2. Tumor Necrosis Factor Receptor-associated Protein 1 (TRAP1) Mutation and TRAP1 Inhibitor Gamitrinib-triphenylphosphonium (G-TPP) Induce a Forkhead Box O (FOXO)-dependent Cell Protective Signal from Mitochondria.
Kim H; Yang J; Kim MJ; Choi S; Chung JR; Kim JM; Yoo YH; Chung J; Koh H
J Biol Chem; 2016 Jan; 291(4):1841-1853. PubMed ID: 26631731
[TBL] [Abstract][Full Text] [Related]
3. Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors.
Park HK; Jeong H; Ko E; Lee G; Lee JE; Lee SK; Lee AJ; Im JY; Hu S; Kim SH; Lee JH; Lee C; Kang S; Kang BH
J Med Chem; 2017 Sep; 60(17):7569-7578. PubMed ID: 28816449
[TBL] [Abstract][Full Text] [Related]
4. New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting.
Rondanin R; Lettini G; Oliva P; Baruchello R; Costantini C; Trapella C; Simoni D; Bernardi T; Sisinni L; Pietrafesa M; Ponterini G; Costi MP; Vignudelli T; Luciani R; Matassa DS; Esposito F; Landriscina M
Bioorg Med Chem Lett; 2018 Jul; 28(13):2289-2293. PubMed ID: 29807796
[TBL] [Abstract][Full Text] [Related]
5. Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1.
Lee C; Park HK; Jeong H; Lim J; Lee AJ; Cheon KY; Kim CS; Thomas AP; Bae B; Kim ND; Kim SH; Suh PG; Ryu JH; Kang BH
J Am Chem Soc; 2015 Apr; 137(13):4358-67. PubMed ID: 25785725
[TBL] [Abstract][Full Text] [Related]
6. Hsp90 inhibitors disrupt mitochondrial homeostasis in cancer cells.
Neckers L; Kern A; Tsutsumi S
Chem Biol; 2007 Nov; 14(11):1204-6. PubMed ID: 18022558
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial chaperone, TRAP1 as a potential pharmacological target to combat cancer metabolism.
Ramkumar B; Dharaskar SP; Mounika G; Paithankar K; Sreedhar AS
Mitochondrion; 2020 Jan; 50():42-50. PubMed ID: 31669620
[TBL] [Abstract][Full Text] [Related]
8. Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1.
Sanchez-Martin C; Menon D; Moroni E; Ferraro M; Masgras I; Elsey J; Arbiser JL; Colombo G; Rasola A
Antioxid Redox Signal; 2021 Mar; 34(7):505-516. PubMed ID: 32438819
[No Abstract] [Full Text] [Related]
9. TRAP1: a viable therapeutic target for future cancer treatments?
Lettini G; Maddalena F; Sisinni L; Condelli V; Matassa DS; Costi MP; Simoni D; Esposito F; Landriscina M
Expert Opin Ther Targets; 2017 Aug; 21(8):805-815. PubMed ID: 28664757
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the mitochondrial Hsp90 chaperone network: a novel, efficient treatment strategy for cancer?
Siegelin MD
Cancer Lett; 2013 Jun; 333(2):133-46. PubMed ID: 23376257
[TBL] [Abstract][Full Text] [Related]
11. TRAP1 Chaperones the Metabolic Switch in Cancer.
Wengert LA; Backe SJ; Bourboulia D; Mollapour M; Woodford MR
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740911
[TBL] [Abstract][Full Text] [Related]
12. The Mitochondrial HSP90 Paralog TRAP1: Structural Dynamics, Interactome, Role in Metabolic Regulation, and Inhibitors.
Joshi A; Ito T; Picard D; Neckers L
Biomolecules; 2022 Jun; 12(7):. PubMed ID: 35883436
[TBL] [Abstract][Full Text] [Related]
13. Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1.
Park HK; Yoon NG; Lee JE; Hu S; Yoon S; Kim SY; Hong JH; Nam D; Chae YC; Park JB; Kang BH
Exp Mol Med; 2020 Jan; 52(1):79-91. PubMed ID: 31956271
[TBL] [Abstract][Full Text] [Related]
14. The molecular chaperone TRAP1 in cancer: From the basics of biology to pharmacological targeting.
Masgras I; Laquatra C; Cannino G; Serapian SA; Colombo G; Rasola A
Semin Cancer Biol; 2021 Nov; 76():45-53. PubMed ID: 34242740
[TBL] [Abstract][Full Text] [Related]
15. Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1.
Sanchez-Martin C; Moroni E; Ferraro M; Laquatra C; Cannino G; Masgras I; Negro A; Quadrelli P; Rasola A; Colombo G
Cell Rep; 2020 Apr; 31(3):107531. PubMed ID: 32320652
[TBL] [Abstract][Full Text] [Related]
16. The hsp90-related protein TRAP1 is a mitochondrial protein with distinct functional properties.
Felts SJ; Owen BA; Nguyen P; Trepel J; Donner DB; Toft DO
J Biol Chem; 2000 Feb; 275(5):3305-12. PubMed ID: 10652318
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells.
Rasola A; Neckers L; Picard D
Trends Cell Biol; 2014 Aug; 24(8):455-63. PubMed ID: 24731398
[TBL] [Abstract][Full Text] [Related]
18. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy.
Landriscina M; Amoroso MR; Piscazzi A; Esposito F
Gynecol Oncol; 2010 May; 117(2):177-82. PubMed ID: 19942270
[TBL] [Abstract][Full Text] [Related]
19. The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis.
Joshi A; Dai L; Liu Y; Lee J; Ghahhari NM; Segala G; Beebe K; Jenkins LM; Lyons GC; Bernasconi L; Tsai FTF; Agard DA; Neckers L; Picard D
BMC Biol; 2020 Jan; 18(1):10. PubMed ID: 31987035
[TBL] [Abstract][Full Text] [Related]
20. Guardian of the furnace: mitochondria, TRAP1, ROS and stem cell maintenance.
Kadye R; Kramer AH; Joos-Vandewalle J; Parsons M; Njengele Z; Hoppe H; Prinsloo E
IUBMB Life; 2014 Jan; 66(1):42-5. PubMed ID: 24382805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]